Related references
Note: Only part of the references are listed.Guidelines on nicotine dose selection for in vivo research
Shannon G. Matta et al.
PSYCHOPHARMACOLOGY (2007)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Differentiating antidepressants of the future: Efficacy and safety
Sharon Rosenzweig-Lipson et al.
PHARMACOLOGY & THERAPEUTICS (2007)
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice
R. L. Rabenstein et al.
PSYCHOPHARMACOLOGY (2006)
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial
F. Joseph McClernon et al.
PSYCHOPHARMACOLOGY (2006)
Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice
Tomasz Kos et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice
Katsuya Suemaru et al.
PHYSIOLOGY & BEHAVIOR (2006)
Evidence of reuptake inhibition responsible for mecamylamine-evoked increases in extracellular serotonin
ZY Ma et al.
BRAIN RESEARCH (2006)
Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: Comparison with risperidone
JT Andreasen et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
The selective α7 nicotinic acetylcholine receptor agonist PNU-282987[N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats
M Hajós et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine
G Vazquez-Palacios et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Primer effects by conspecific odors in house mice: a new perspective in the study of primer effects on reproductive activities
S Koyama
HORMONES AND BEHAVIOR (2004)
Mechanism of action of A-85380 in an animal model of depression
MJ Buckley et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Clinical pharmacology of MAO inhibitors: Safety and future
M Yamada et al.
NEUROTOXICOLOGY (2004)
High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation
BJ Caldarone et al.
BIOLOGICAL PSYCHIATRY (2004)
Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors
J Garcia-Colunga et al.
PHARMACOGENOMICS JOURNAL (2004)
Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine
G Vázquez-Palacios et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)
Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function
John D Fryer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Different data from different labs: Lessons from studies of gene-environment interaction
D Wahlsten et al.
JOURNAL OF NEUROBIOLOGY (2003)
Effect of nicotine and nicotinic receptors on anxiety and depression
MR Picciotto et al.
NEUROREPORT (2002)
Nicotinic acetylcholine receptors as targets for antidepressants
RD Shytle et al.
MOLECULAR PSYCHIATRY (2002)
Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release
PJ Kenny et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression
SM Ferguson et al.
PSYCHOPHARMACOLOGY (2000)
Depressive characteristics of FSL rats: Involvement of central nicotinic receptors
Y Tizabi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression
JM Kent
LANCET (2000)
The association between depressive symptoms and cigarette smoking in an urban primary care sample
C Brown et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2000)
Cardiac disorders and antidepressant medications
JB Murray
JOURNAL OF PSYCHOLOGY (2000)
Share Paper
